Please login to bookmark Close

Johnson & Johnson has agreed to pay $7.9 billion to resolve multi-district litigation in the US alleging its talcum powder caused cancer, a settlement Shine Lawyers said was a positive development as it readies for a first case management hearing in its class action.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au